VR Logo

ANG Lifesciences India Ltd. download report


Healthcare | Drugs & Pharma

ANG Lifesciences India Ltd. Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 ANG Lifesciences India Ltd. Annual Report ANG Lifesciences India Ltd. director's report ANG Lifesciences India Ltd. management discussion ANG Lifesciences India Ltd. auditor's report ANG Lifesciences India Ltd. account notes
2020 ANG Lifesciences India Ltd. Annual Report ANG Lifesciences India Ltd. chairman speech ANG Lifesciences India Ltd. director's report ANG Lifesciences India Ltd. management discussion ANG Lifesciences India Ltd. corporate governance ANG Lifesciences India Ltd. auditor's report ANG Lifesciences India Ltd. account notes
2019 ANG Lifesciences India Ltd. Annual Report ANG Lifesciences India Ltd. chairman speech ANG Lifesciences India Ltd. director's report ANG Lifesciences India Ltd. management discussion ANG Lifesciences India Ltd. corporate governance ANG Lifesciences India Ltd. auditor's report ANG Lifesciences India Ltd. account notes
2018 ANG Lifesciences India Ltd. Annual Report ANG Lifesciences India Ltd. chairman speech ANG Lifesciences India Ltd. director's report ANG Lifesciences India Ltd. management discussion ANG Lifesciences India Ltd. corporate governance ANG Lifesciences India Ltd. auditor's report ANG Lifesciences India Ltd. account notes

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 2006

Chairman: --

Managing Director: Rajesh Gupta

Listing: BSE: 540694

Country: India

Headquarters: Amritsar, Punjab

Website: www.anglifesciences.com

Key Facts

Market cap: ₹207.02 Cr

Revenue (TTM): ₹154.38 Cr

Earnings (TTM): ₹7.03 Cr

Cash: ₹3.86 Cr

Total Debt: ₹43.16 Cr

Promoters' ownership: 71.14%

Liquidity: Moderate

52 Week range: ₹53.05 - 800.45

Face value: ₹10.00

Shares outstanding: 1,03,66,630

10 Years Aggregate:

  • CFO: ₹35.29 Cr
  • EBITDA: ₹68.99 Cr
  • Net Profit: ₹25.80 Cr

Stock Performance

Time Period ANG Lifesciences S&P BSE Healthcare S&P BSE Small Cap
YTD-57.48-17.06-15.25
1 month-22.94-3.28-2.56
3 months-20.74-10.69-10.20
1 Year141.77-13.41-0.12
3 Years111.1919.0520.55
5 Years--9.2310.52
10 Years--12.3914.50
As on 28-Jun-2022
Year ANG Lifesciences S&P BSE Small Cap S&P BSE Healthcare
20211,194.6862.7720.87
202082.2532.1161.45
20194.16-6.85-3.55
2018-49.22-23.41-5.89